The United States and New Zealand are the only high-income countries that permit direct-to-consumer advertising of prescription drugs. American pharmaceutical companies spent $6.58 billion on it in 2020, up more than tenfold from 1996.
The standard closing line of every one of those advertisements is an instruction to the patient: ask your doctor about it. The system is built on the assumption that the patient will raise the subject, not that the physician will.